5 results on '"Shahar Lavi"'
Search Results
2. Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI
- Author
-
Warren J. Cantor, Andrew Yang, Sebastian Harenberg, Sheila Kelly, Jeff Booker, Akshay Bagai, Asim N. Cheema, Shamir R. Mehta, Quin Pon, Payam Dehghani, Shahar Lavi, Jennifer J. Crawford, Andrea Lavoie, Rodney Zimmermann, and Shaun G. Goodman
- Subjects
Male ,Ticagrelor ,medicine.medical_specialty ,Adenosine ,Ticlopidine ,Time Factors ,medicine.medical_treatment ,Tenecteplase ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Internal medicine ,Fibrinolysis ,Humans ,Medicine ,Thrombolytic Therapy ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Aged ,Aspirin ,business.industry ,Percutaneous coronary intervention ,Hematology ,Middle Aged ,medicine.disease ,Clopidogrel ,Treatment Outcome ,Conventional PCI ,Cardiology ,ST Elevation Myocardial Infarction ,Female ,Cardiology and Cardiovascular Medicine ,business ,Platelet Aggregation Inhibitors ,Follow-Up Studies ,medicine.drug - Abstract
The long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in patients undergoing early percutaneous coronary intervention (PCI) after fibrinolytic therapy is unknown. From May 2014 to August 2016, 212 patients undergoing PCI within 24 h of Tenecteplase (TNK), Aspirin, and Clopidogrel for ST-elevated myocardial infarction (STEMI) were randomized at four Canadian sites to receive additional Clopidogrel or Ticagrelor initiated prior to PCI. The platelet reactivity units (PRU) were measured with the VerifyNow Assay before study drug administration (baseline), at 4 and 24 h post PCI, and follow-up appointment. A mixed-model analysis with time as the repeated measure and drug as the between-subjects factor was calculated using 2 separate 1 × 4 ANOVAs, with students t-tests used to compare drugs within each time point. Complete clinical follow-up data (median 115.0 days; IQR 80.3–168.8) was available in 50 patients (23.6%) randomized to either Clopidogrel (n = 23) or Ticagrelor (n = 27). Analyses revealed significant decreases in PRU from baseline to 4 h (261.4 vs. 71.7; Mdiff = − 189.7; p
- Published
- 2017
3. Untreated preoperative depression is not associated with postoperative arrhythmias in CABG patients
- Author
-
Ronit Lavi, Matthew Machina, Shahar Lavi, W. Scott Beattie, Rita Katznelson, George Djaiani, and Vivek Rao
- Subjects
Male ,medicine.medical_specialty ,Ventricular tachycardia ,Postoperative Complications ,Risk Factors ,Surveys and Questionnaires ,Internal medicine ,Heart rate ,Humans ,Medicine ,Prospective Studies ,cardiovascular diseases ,Coronary Artery Bypass ,Depression (differential diagnoses) ,Aged ,medicine.diagnostic_test ,Depression ,business.industry ,Incidence ,Age Factors ,Arrhythmias, Cardiac ,Atrial fibrillation ,General Medicine ,Middle Aged ,medicine.disease ,Patient Health Questionnaire ,Anesthesiology and Pain Medicine ,Elective Surgical Procedures ,Anesthesia ,Multivariate Analysis ,Ventricular fibrillation ,Electrocardiography, Ambulatory ,cardiovascular system ,Cardiology ,Regression Analysis ,Female ,Supraventricular tachycardia ,business ,Electrocardiography - Abstract
The mechanism by which depression affects postoperative outcome may involve arrhythmias. The purpose of this study was to evaluate whether untreated depression is associated with an increased incidence of postoperative arrhythmias in patients undergoing coronary artery bypass graft surgery (CABG).One hundred seven patients were assessed for signs of depression with the Prime-MD Patient Health Questionnaire (brief PHQ) one week before surgery and subsequently underwent Holter monitoring for 48-72 hr postoperatively. The incidences of atrial fibrillation (AF); supraventricular tachycardia (SVT); ventricular tachycardia (VT), defined as three or more consecutive beats at a cycle length less than 600 msec; ventricular fibrillation (VF); and average heart rate (HR) were recorded in patients with and without signs of depression.The incidence of preoperative untreated depression was 27% (29/107). Twenty patients had mild depression (brief PHQ score of 5-9), seven patients had moderate depression (a score of 10-14), and two patients had severe depression (a score of 20). The incidences of postoperative AF, SVT, and non-sustained VT in depressed and non-depressed patients were 37.9% vs 35.9%, respectively (P = 0.50), 34.4% vs 52.5%, respectively (P = 0.07), and 17.2% vs 37.1%, respectively (P = 0.04). The average (SD) postoperative HR was similar in both groups [95 (12) beats·min(-1) in depressed patients and 92 (10) beats·min(-1) in non-depressed patients, (P = 0.25)]. Multivariate regression analysis showed that older age, but not depression, was a risk factor for postoperative arrhythmia.Preoperative untreated depression is not related to postoperative arrhythmia in the early postoperative period in patients undergoing elective CABG. This trial was registered at clinicaltrials.gov (number: NCT00622024).
- Published
- 2013
4. Sex differences in vascular and endothelial responses to acute mental stress
- Author
-
Amir Lerman, Lilach O. Lerman, Leslie R. MacBride, Shen Li Tan, Shahar Lavi, and Elizabeth A. Martin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Neurology ,Heart disease ,Endothelium ,Manometry ,Blood Pressure ,Article ,Sex Factors ,Heart Rate ,Diabetes mellitus ,Internal medicine ,Heart rate ,Humans ,Medicine ,Endocrine and Autonomic Systems ,business.industry ,Mechanism (biology) ,medicine.disease ,medicine.anatomical_structure ,Blood pressure ,Vascular resistance ,Cardiology ,Blood Vessels ,Female ,Vascular Resistance ,Endothelium, Vascular ,Neurology (clinical) ,business ,Stress, Psychological - Abstract
Our objective was to assess the differences in systemic vascular and endothelial function in response to acute mental stress between men and women. The endothelium plays a pivotal role in vascular homeostasis and the development of atherosclerotic heart disease. The mechanism and presentation of cardiovascular events show a sex-based difference, although the sex difference in the vascular and endothelial response to mental stress is not known.Male (n = 34) and female (n = 53) subjects participated in a series of three different mental stress tasks during which vascular response was measured non-invasively using peripheral arterial tonometry. Endothelial function was assessed using reactive hyperemia peripheral arterial tonometry. Double product (systolic blood pressure x heart rate) was calculated.Males had a greater double product response (27.2 + 3.6% increase in double product vs. 19.2 + 1.7%; P = 0.01), and a greater vascular reactivity to mental stress. Females demonstrated a reduced response to reactive hyperemia (-0.47 vs. 13.74%; P = 0.01). Furthermore, a subgroup of females who showed the least vaso-reactivity to mental stress showed the greatest decline in endothelial function (-10.5 + 4% vs. 17.4 + 6.3%; P0.001).This study demonstrates sex-based differences in the vascular and endothelial responses to mental stress. The mental stress-induced reduction in endothelial function and increased double product seen in the females might manifest clinically as contributing to the pathophysiology of mental stress-mediated cardiovascular events in female patients and provide further information regarding the potential mechanism for sex differences in cardiac events.
- Published
- 2008
5. Role of lipoprotein-associated phospholipase A2 in atherosclerosis
- Author
-
Ronit Lavi, Shahar Lavi, Joerg Herrmann, Lilach O. Lerman, Amir Lerman, and Joseph P. McConnell
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,Coronary Disease ,Disease ,Bioinformatics ,Phospholipase A2 ,Risk Factors ,Internal medicine ,medicine ,Humans ,Acute Coronary Syndrome ,Risk factor ,Hypolipidemic Agents ,biology ,business.industry ,Lipoprotein-associated phospholipase A2 ,Atherosclerotic disease ,Endothelial Cells ,Atherosclerosis ,Prognosis ,medicine.disease ,Pathophysiology ,Biomarker (cell) ,Stroke ,Endocrinology ,1-Alkyl-2-acetylglycerophosphocholine Esterase ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers - Abstract
Lipoprotein-associated phospholipase A(2)(Lp-PLA(2)) is a biomarker that can be used to assess the risk for cardiovascular disease and events. In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA(2) has a pathophysiologic role in the atherosclerotic disease process. In this article, we review this aspect and its therapeutic implications.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.